Proteinuria in Diabetes: Bystander or Pathway to Cardiorenal Disease?KARALLIEDDE, Janaka; VIBERTI, Giancarlo.Journal of the American Society of Nephrology. 2010, Vol 21, Num 12, pp 2020-2027, issn 1046-6673, 8 p.Article

Thiazolidinediones and their fluid-related adverse effects : Facts, fiction and putative management strategiesKARALLIEDDE, Janaka; BUCKINGHAM, Robin E.Drug safety. 2007, Vol 30, Num 9, pp 741-753, issn 0114-5916, 13 p.Article

ACCORD and ADVANCE : a tale of two studies on the merits of glycaemic control in type 2 diabetic patientsKARALLIEDDE, Janaka; GNUDI, Luigi.Nephrology, dialysis, transplantation (Print). 2008, Vol 23, Num 6, pp 1796-1798, issn 0931-0509, 3 p.Article

Targeting albumin excretion rate in the treatment of the hypertensive diabetic patient with renal diseaseKRIMHOLTZ, Michael J; KARALLIEDDE, Janaka; THOMAS, Stephen et al.Journal of the American Society of Nephrology. 2005, Vol 16, pp S42-S47, issn 1046-6673, SUP1Conference Paper

Effect of various diuretic treatments on rosiglitazone-induced fluid retentionKARALLIEDDE, Janaka; BUCKINGHAM, Robin; STARKIE, Margaret et al.Journal of the American Society of Nephrology. 2006, Vol 17, Num 12, pp 3482-3490, issn 1046-6673, 9 p.Article